The Panel on Food Additives and Nutrient Sources added to Food (ANS) has previously provided a scientific opinion re‐evaluating the safety of β‐apo‐8′‐carotenal (E 160e) as a food additive in the EU and establishing an acceptable daily intake (ADI) of 0.05 mg/kg body weight (bw)/day (EFSA ANS Panel, 2012). Following a request by the European Commission, the ANS Panel was asked to consider newly submitted information on the interpretation of the 13‐week study in rats used as a basis to establish the ADI, to clarify its impact on that ADI and to carry out the refined exposure assessment of β‐apo‐8′‐carotenal. The new information comprised an evaluation of all of the original kidney section slides from the 13‐week toxicological study under improved visualisation conditions. The ANS Panel has considered that the supplementary information provided by the Commission and the present toxicological database on β‐apo‐8′‐carotenal provides a basis to revise the established ADI and concluded that, based on the NOAEL of 30 mg/kg bw/day from the 13‐week study in rats and an uncertainty factor of 100, a new ADI for β‐apo‐8′‐carotenal of 0.3 mg/kg bw/day can be established. The Panel concluded that using data provided by the food industry, which are based only on a limited number of regulated categories, the reported uses and use levels of β‐apo‐8’‐carotenal (E 160e) would not be of safety concern.